Biomarin Pharmaceutical Inc Tangible Net Worth Ratio
Biomarin Pharmaceutical Inc tangible net worth ratio. Biomarin Pharmaceutical Inc (BMRN) has a Tangible Net Worth Ratio of 22.8% as of June 2026. This metric is calculated by deducting intangible assets ($4.88 Billion) from net assets ($6.32 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check BMRN capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Biomarin Pharmaceutical Inc (1998–2025)
Tangible net worth ratio of Biomarin Pharmaceutical Inc from 1998 to 2025. This chart shows how Biomarin Pharmaceutical Inc's Tangible Net Worth Ratio has changed across 26 annual periods from 1998 to 2025. As of June 2026, the ratio stands at 22.8%, reflecting net assets of $6.32 Billion with intangible assets of $4.88 Billion USD. See BMRN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Biomarin Pharmaceutical Inc Tangible Net Worth Ratio by Year (1998–2025)
Biomarin Pharmaceutical Inc tangible net worth ratio by year from 1998 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see BMRN market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | $6.09 Billion | $213.84 Million | $7.59 Billion | ▲ +1.0 pp |
| 2024 | 95.5% | $5.66 Billion | $255.28 Million | $6.99 Billion | ▲ +1.4 pp |
| 2023 | 94.0% | $4.95 Billion | $294.70 Million | $6.84 Billion | ▲ +1.4 pp |
| 2022 | 92.6% | $4.60 Billion | $338.57 Million | $6.38 Billion | ▲ +1.7 pp |
| 2021 | 90.9% | $4.27 Billion | $388.65 Million | $6.00 Billion | ▲ +1.1 pp |
| 2020 | 89.8% | $4.11 Billion | $417.27 Million | $5.85 Billion | ▲ +4.5 pp |
| 2019 | 85.4% | $3.12 Billion | $456.58 Million | $4.69 Billion | ▲ +1.9 pp |
| 2018 | 83.4% | $2.97 Billion | $491.81 Million | $4.43 Billion | ▲ +1.9 pp |
| 2017 | 81.6% | $2.81 Billion | $517.51 Million | $4.63 Billion | ▲ +1.6 pp |
| 2016 | 80.0% | $2.77 Billion | $553.78 Million | $4.02 Billion | ▲ +8.5 pp |
| 2015 | 71.5% | $2.40 Billion | $684.00 Million | $3.73 Billion | ▼ -18.2 pp |
| 2014 | 89.8% | $1.53 Billion | $156.58 Million | $2.49 Billion | ▲ +1.9 pp |
| 2013 | 87.8% | $1.34 Billion | $163.15 Million | $2.24 Billion | ▲ +3.9 pp |
| 2012 | 84.0% | $1.02 Billion | $162.98 Million | $1.57 Billion | ▲ +7.3 pp |
| 2011 | 76.7% | $773.05 Million | $180.28 Million | $1.31 Billion | ▼ -8.9 pp |
| 2010 | 85.5% | $717.26 Million | $103.65 Million | $1.26 Billion | ▼ -1.7 pp |
| 2009 | 87.3% | $322.19 Million | $40.98 Million | $917.16 Million | ▼ -10.0 pp |
| 2008 | 97.2% | $276.68 Million | $7.63 Million | $906.70 Million | ▲ +2.4 pp |
| 2007 | 94.9% | $187.73 Million | $9.60 Million | $815.28 Million | ▲ +4.8 pp |
| 2006 | 90.1% | $117.80 Million | $11.65 Million | $463.44 Million | ▼ -9.9 pp |
| 2003 | 100.0% | $117.85 Million | $0.00 | $256.34 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $98.54 Million | $0.00 | $110.62 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $159.55 Million | $0.00 | $171.81 Million | ▲ +14.1 pp |
| 2000 | 85.9% | $69.99 Million | $9.86 Million | $76.93 Million | ▼ -2.4 pp |
| 1999 | 88.3% | $98.38 Million | $11.46 Million | $103.55 Million | ▲ +28.1 pp |
| 1998 | 60.2% | $29.40 Million | $11.70 Million | $31.51 Million | — |